-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-2-tech-specs.pdf
June 02, 2025 - Section 2, Technical Specifications
Sepsis
Measure 3: Timely Blood Culture for Children with Sepsis Syndrome
Description
The proportion of hospitalized children with sepsis syndrome who had blood culture drawn within 4 hours
of meeting diagnostic criteria for sepsis syndrome. A higher proportion indic…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
August 01, 2014 - Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications
Q-METRIC Sepsis Measure 4, Timely Administration of Antibiotics for Severe Sepsis and Septic Shock
U18HS020516 Page 50
Submitted August 2014
Sepsis
Measure 4: Timely Antibiotics for Children with Severe Sepsis or …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-tables-2-5.pdf
June 02, 2025 - Tables 2-5
TABLE 2
High-risk referral center Not a high-risk referral
center
P-value
Facility Type
Community hospital 61 (58.7%) 207 …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-tables-7-10.pdf
June 02, 2025 - Tables 7-10
TABLE 7
Quantile
Percent in Poverty
Maximum 49.9%
99 37.5%
95 28.9%
90 25.7%
75 20.7%
50 16.5%
25 12.5%
10 10.0%
5 8.6%
1 6.1%
Minimum 2.9%
TABLE 8
HROB Summary (Combined Unduplicated)
New York State Medicaid, 2010
Poverty
Level
N OB
Proxy1
Transfusion
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
January 01, 2014 - Table 5.A.1. Evidence Table
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-6a-flow-chart.pdf
June 02, 2025 - Section 6.A Flow Chart
Figure VI.A.1 – Flowchart of the medical record review process in the GAPPS study
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-section-6-tables-1a.pdf
June 02, 2025 - Table 1a. ADAPT Survey Respondent Characteristics
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-241-bmi-communication-full-report.pdf
February 01, 2020 - Measure Categories
CHIPRA legislation requires that measures in the initial and improved core set, taken … for the focus of the measures will be made explicit and transparent as
part of the public release of CHIPRA … Identification of Disparities
CHIPRA requires that quality measures be able to identify disparities … Levels of Aggregation
CHIPRA states that data used in quality measures must be collected and reported … Understandability
CHIPRA states that the core set should allow purchasers, families, and health care
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-tables%201-7.pdf
June 02, 2025 - Tables 1-7
Table 1. Contingency Table for Presence of Chart Review Exclusions
Senior Abstractor
Identified Chart-Based Exclusion
Present Absent Total
Abstractor
Identified Chart-Based Exclusion
Present 67 2 69
Absent 0 372 372
Total 67 374 441
Table 2. Contingency Table for Presence of S…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-figures-1-3.pdf
June 30, 2015 - Figures 1-3
Figure 1. Path Between the Measure Focus and Health Outcome
Child Suffers
Post-Traumatic
Headache and
Seeks ED Care
•Without signs or
symptoms of
intracranial injury
•Without history of a
condition that would
warrant imaging
CT Scan or MRI
Overuse
•Imaging obtained
without lik…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0192-table11-figures1-2.pdf
May 15, 2015 - Overuse of Imaging for the Evaluation of Children with Simple Febrile Seizure: Table 11 and Figures 1 & 2
Table 11: Evidence Regarding Overuse of Imaging for the Evaluation of Children with Simple Febrile Seizure
Type of
Evidence
Key Findings
Level of
Evidence
(USPSTF
Ranking*)
Citations
Clinica…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-7-d-tables.pdf
June 02, 2025 - Section 7-D, Tables 7-D.1 and 7-D.2
Red Cell Transfusions – Attachment 7.D.
Table 7.D.1.
Geographic Location % of…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-table6-figs1-2.pdf
July 16, 2015 - Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Seizure: Table 6 and Figures 1 & 2
Table 6: Evidence Regarding Overuse of Imaging for Atraumatic Seizures in Children
Type of
Evidence
Key Findings
Level of
Evidence
(USPSTF
Ranking*) …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-3-a-tables.pdf
June 02, 2025 - Section 3-A, Tables
Outcome Transfused Not transfused P value
Patients 131 109
Average entry Hb 6.9 g/dL 8.1 g/dL < 0.001
Hospital mortality 8 (6.1%) 1 (0.9%) 0.043
Average oxygen days 8.0 ± 10.4 days 4.0 ± 6.6 days < 0.001
Mechanical ventilator days 5.6 ± 9.1 days 2.4 ± 4.1 days 0.002
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-scd-ed-tech-specs.pdf
June 02, 2025 - Appropriate Emergency Department Blood Testing for Children with Sickle Cell Disease
Sickle Cell Disease
Measure 14: Appropriate Emergency Department Blood Testing for
Children with Sickle Cell Disease
Description
The percentage of children identified as having Sickle Cell Disease presenting to an eme…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-section-2-tech-specs.pdf
June 02, 2025 - with financial support from the Agency for Healthcare Research and Quality (AHRQ) and
CMS under the CHIPRA
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-113-section-2-tech-specs.pdf
December 01, 2011 - Section 2, Technical Specifications
Technical Specifications: Rate of ED Visit Use for Children Managed for
Identifiable Asthma
Calculation
a. Step 1: Measure person-time eligible for each patient and record by month.
i. a. For each month in the reporting year, identify all children ages 2 – 21 years
wh…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-section-2-tech-specs.pdf
November 01, 2014 - National Collaborative for Innovation in Quality Measurement--Metabolic Monitoring for Children and Adolescents on Antipsychotics
1
National Collaborative for Innovation in Quality Measurement
Metabolic Monitoring for Children and Adolescents on Antipsychotics
Administrative Specification for Sta…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0198-table10-figures1-2.pdf
July 16, 2015 - Overuse of Computed Tomography Scans for the Evaluation of Children with a First Generalized Afebrile, Atraumatic Seizure: Table 10 and Figures 1 & 2
Table 10: Evidence Regarding Overuse of Imaging for the Evaluation of Children with Afebrile, Atraumatic
Seizures
Type of
Evidence
Key Findings
Level of
Ev…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-tables%208-11.pdf
June 02, 2025 - Tables 8-11
Table 8. Mean (SD) Proportion of Racial Groups within Sampled ZIP Codes of Residence‡
Sampled Group
Description
American
Indian or
Alaska
Native
Mean(SD)‡
Asian
Mean(SD)‡
Black or
African
American
Mean(SD)‡
Native
Hawaiian or
Other Pacific
Islander
Mean(SD)‡
White
Mean(SD)‡
…